Diabetes
Hepatitis C Patients at Higher Risk after Liver Transplantation
Published in Hepatitis Weekly, August 28th, 2000
Research results produced by these scientists suggest that patients who must have liver transplants as a result of hepatitis-C-related chronic liver disease are more at risk for diabetes both before and after their surgery.
In this study, D.L. Bigam and colleagues at Toronto General Hospital investigated the prevalence of diabetes in 278 patients who had liver transplants as a result of liver failure. Causes of liver failure included hepatitis C virus (HCV) (n=110), hepatitis B virus (HBV) (n=53), and cholestatic liver disease (CLD)...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Hepatitis Weekly
Source: Hepatitis Weekly (2000-08-28)
More Articles from Hepatitis Weekly
- Immunization
Vaccine Program in Pacific Islands Leads to Lower Hepatitis B Rates in Children - Epidemiology
Study Finds High Hepatitis C Virus Infection Rate in Southern Italian Town - Interferon Therapy
First Response to Interferon-(alpha) Predicts Subsequent Response - Steatosis
Hepatitis C Virus Genotype 3 Associated with Fatty Liver Syndrome - Occupational Risk
Urban Paramedics have Higher Hepatitis C Infection Rate than General Population - Risk Factors
Molecular Interactions a Key to Hepatitis B Infection Risk in Men - More from this issue of Hepatitis Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
